(MDB) MongoDB - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US60937P1066

MDB: Atlas, Enterprise, Community, Consulting, Training, Database, Platform

MongoDB, Inc. (NASDAQ:MDB) is a leading provider of a modern, general-purpose database platform designed to handle various data types and scaling requirements. The companys flagship product, MongoDB, is a NoSQL database known for its document-based data model, which allows for flexible schema design and high scalability. MongoDB Atlas, its cloud-based database-as-a-service (DBaaS) offering, enables multi-cloud deployments across AWS, Azure, and Google Cloud, providing enterprises with increased agility and reduced vendor lock-in. MongoDB Enterprise Advanced extends this functionality for on-premises and hybrid environments, catering to large organizations with advanced security, monitoring, and compliance needs. The Community Server remains a free, open-source version of the database, fostering a developer-friendly ecosystem and driving adoption across startups and small businesses. MongoDB also offers professional services, including consulting, training, and customer support, to help organizations optimize their database strategies and migrations.

Founded in 2007 under the name 10gen, Inc., MongoDB, Inc. rebranded in 2013 to align its corporate identity with its core product. Headquartered in New York City, the company has established itself as a pioneer in the NoSQL database market, with a strong focus on innovation in cloud-native technologies, real-time data processing, and event-driven architectures. MongoDBs platform is widely used across industries, including fintech, healthcare, gaming, and e-commerce, where high performance, scalability, and developer productivity are critical.

From a financial perspective, MongoDB operates with a market capitalization of $12.31 billion as of the latest data. The companys forward P/E ratio stands at 61.73, reflecting investor expectations for future growth despite the absence of current profitability (P/E: None). The price-to-book (P/B) ratio of 4.65 indicates a premium valuation relative to its book value, while the price-to-sales (P/S) ratio of 6.14 highlights the markets confidence in its revenue growth potential. However, the return on equity (RoE) of -4.64% underscores the companys ongoing investments in research and development, as well as its focus on expanding its customer base and product offerings.

Over the next three months, MongoDBs stock (MDB) is expected to experience volatility, influenced by both technical and fundamental factors. Technically, the stock is currently trading below its 20-day and 50-day simple moving averages (SMA), with the last price of $152.15 falling short of the SMA 20 ($166.83) and SMA 50 ($210.35). This suggests near-term weakness, potentially driven by broader market sentiment or profit-taking. However, the average true range (ATR) of 10.47 indicates moderate volatility, which could lead to price swings within a range of $135 to $170 in the first month.

Fundamentally, MongoDBs forward P/E of 61.73 suggests that investors are pricing in strong revenue growth, particularly as the company continues to expand its cloud-based offerings and enterprise adoption. If MongoDB delivers on its earnings expectations and demonstrates continued momentum in its Atlas platform, the stock could rebound and test the SMA 50 level ($210.35) by the end of the second month. This would require positive macroeconomic conditions and strong execution on product innovation and customer acquisition.

By the third month, MongoDBs stock could enter a consolidation phase, with technical indicators providing mixed signals. If the company reports strong quarterly results and guidance, the stock may break above its SMA 200 ($254.67), signaling a bullish trend. Conversely, any signs of slowing growth or increased competition in the database market could lead to a retest of the lower end of its trading range. Based on current data, the stock is expected to trade within a range of $220 to $250 by the end of the third month, assuming no major external shocks or changes in market sentiment.

Additional Sources for MDB Stock

MDB Stock Overview

Market Cap in USD 12,314m
Sector Technology
Industry Software - Infrastructure
GiC Sub-Industry Internet Services & Infrastructure
IPO / Inception 2017-10-19

MDB Stock Ratings

Growth Rating -5.60
Fundamental 16.6
Dividend Rating 0.0
Rel. Strength -55.4
Analysts 4.25/5
Fair Price Momentum 142.27 USD
Fair Price DCF 14.09 USD

MDB Dividends

No Dividends Paid

MDB Growth Ratios

Growth Correlation 3m -90.8%
Growth Correlation 12m -36.4%
Growth Correlation 5y -2.1%
CAGR 5y 1.58%
CAGR/Max DD 5y 0.02
Sharpe Ratio 12m -0.38
Alpha -69.18
Beta 1.886
Volatility 87.96%
Current Volume 2105.6k
Average Volume 20d 2583.6k
What is the price of MDB stocks?
As of April 26, 2025, the stock is trading at USD 173.50 with a total of 2,105,614 shares traded.
Over the past week, the price has changed by +14.39%, over one month by -12.66%, over three months by -34.42% and over the past year by -52.61%.
Is MongoDB a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, MongoDB is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.59 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of MDB as of April 2025 is 142.27. This means that MDB is currently overvalued and has a potential downside of -18%.
Is MDB a buy, sell or hold?
MongoDB has received a consensus analysts rating of 4.25. Therefor, it is recommend to buy MDB.
  • Strong Buy: 19
  • Buy: 9
  • Hold: 7
  • Sell: 0
  • Strong Sell: 1
What are the forecast for MDB stock price target?
According to ValueRays Forecast Model, MDB MongoDB will be worth about 166.8 in April 2026. The stock is currently trading at 173.50. This means that the stock has a potential downside of -3.86%.
Issuer Forecast Upside
Wallstreet Target Price 284.4 63.9%
Analysts Target Price 374.8 116%
ValueRay Target Price 166.8 -3.9%